Project Grant 2019PMBX0008

The Department of Health and Human Services Agency for Healthcare Research and Quality awarded Oregon State University a $740,620 Project Grant under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) to evaluate the integration of state prescription drug monitoring programs into electronic health records. Oregon Health & Science University and Comagine Health were named as sub-awardees to provide integration services for OHSU's Epic EHR system and support...

PROMOTE Study: Shared Decision Making Implementation in Opioid Treatment Programs The University of Pittsburgh received a $488,334 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the PERSONALIZED METHADONE TREATMENT (PROMOTE) study. The award, obligated on September 30, 2025, with completion targeted for August 31, 2027, supports a hybrid type 3 implementation-effectiveness trial designed to adapt and...

The State of Alaska Department of Health received a $1,266,452 Project Grant from the U.S. Department of Justice, Bureau of Justice Assistance, under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754). This funding will allow Alaska to advance existing and implement new strategies to monitor controlled substance prescriptions through the state's Prescription Drug Monitoring Program (PDMP). Key objectives include: providing resources to assist with PDMP compliance monitoring and...

This $1.4 million cooperative agreement from the Department of Justice Office of Justice Programs Bureau of Justice Assistance will support implementation of Missouri's first statewide prescription drug monitoring program under the Harold Rogers Prescription Drug Monitoring Program. The Joint Oversight Task Force for Prescription Drug Monitoring will utilize funding to train and educate prescribers and dispensers throughout the state on processes to submit data and comply with Missouri law. This...

The California Department of Justice was awarded a $1.4 million cooperative agreement from the Department of Justice Office of Justice Programs Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program for the period of October 1, 2022 through September 30, 2025. The funding will support enhancements to California's Controlled Substance Utilization Review and Evaluation System including an evaluation of current reporting tools and implementation of system...

The Illinois Department of Human Services (IDHS) received a $2,000,000 Project Grant from the U.S. Department of Justice, Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754). The grant funds will be used to enhance the state's Prescription Monitoring Program (PMP) by facilitating information exchange, providing training for system users, producing educational materials, supporting collaboration among public health and treatment providers,...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $823,809 to the University of Pittsburgh to develop and validate a suite of multidimensional measures of access to Medications for Opioid Use Disorder (MOUD) across U.S. states and the District of Columbia. The primary objectives are to: Create a Small Area Multidimensional MOUD Access (SAMMA) measure suite using public data sources. Validate and...

TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care Oregon Health & Science University received a $2.44M Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to implement and evaluate tobacco cessation outreach interventions in primary care settings. The project, awarded July 15, 2025 with completion targeted for March 31, 2030, addresses the critical public health challenge of tobacco use disorder,...

This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...

Federal Cooperative Agreement Summary The University of Pennsylvania received a $449,998 Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Environmental Health under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), effective September 30, 2025, through September 29, 2029. The project, titled "Pragmatic Implementation of Strategic Interventions to Improve Initiation of Medication for Opioid...